Evidence map›Paper›PMID 33033053›Full record

ReviewBMJ global health2020

The value proposition of the Global Health Security Index.

Sanjana J Ravi, Kelsey Lane Warmbrod, Lucia Mullen, Diane Meyer, Elizabeth Cameron, Jessica Bell, Priya Bapat, Michael Paterra, Catherine Machalaba, Indira Nath and 8 more

Abstract readReview
In one paragraph

Review in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sanjana J RaviJohns Hopkins Center for Health Security, Baltimore, Maryland, USA sanjana@jhu.edu.ORCID 0000-0001-9769-6814
Kelsey Lane WarmbrodJohns Hopkins Center for Health Security, Baltimore, Maryland, USA.
Lucia MullenJohns Hopkins Center for Health Security, Baltimore, Maryland, USA.
Diane MeyerJohns Hopkins Center for Health Security, Baltimore, Maryland, USA.
Elizabeth CameronNuclear Threat Initiative, Washington, DC, USA.
Jessica BellNuclear Threat Initiative, Washington, DC, USA.
Priya BapatEconomist Intelligence Unit, London, UK.
Michael PaterraEconomist Intelligence Unit, London, UK.
Catherine MachalabaEcoHealth Alliance, New York, New York, USA.
Indira NathDepartment of Biotechnology, All India Institute of Medical Sciences, New Delhi, India.
Lawrence O GostinO'Neill Institute for National and Global Health Law, Georgetown Law, Washington, DC, USA.
Wilmot JamesInstitute for Social and Economic Research and Policy, Columbia University, New York, New York, USA.
Dylan GeorgeIn-Q-Tel, Arlington, Virginia, USA.
Simo NikkariCentre for Biothreat Preparedness, Helsinki, Finland.
Ernesto GozzerUniversidad Peruana Cayetano Heredia, Lima, Peru.
Oyewale TomoriThe Nigerian Academy of Science, Lagos, Nigeria.
Issa MakumbiRepublic of Uganda Ministry of Health, Kampala, Uganda.
Jennifer B NuzzoJohns Hopkins Center for Health Security, Baltimore, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious disease outbreaks pose major threats to human health and security. Countries with robust capacities for preventing, detecting and responding to outbreaks can avert many of the social, political, economic and health system costs of such crises. The Global Health Security Index (GHS Index)-the first comprehensive assessment and benchmarking of health security and related capabilities across 195 countries-recently found that no country is sufficiently prepared for epidemics or pandemics. The GHS Index can help health security stakeholders identify areas of weakness, as well as opportunities to collaborate across sectors, collectively strengthen health systems and achieve shared public health goals. Some scholars have recently offered constructive critiques of the GHS Index's approach to scoring and ranking countries; its weighting of select indicators; its emphasis on transparency; its focus on biosecurity and biosafety capacities; and divergence between select country scores and corresponding COVID-19-associated caseloads, morbidity, and mortality. Here, we (1) describe the practical value of the GHS Index; (2) present potential use cases to help policymakers and practitioners maximise the utility of the tool; (3) discuss the importance of scoring and ranking; (4) describe the robust methodology underpinning country scores and ranks; (5) highlight the GHS Index's emphasis on transparency and (6) articulate caveats for users wishing to use GHS Index data in health security research, policymaking and practice.

Indexed as

Global HealthBenchmarkingBetacoronavirusCoronavirus InfectionsCOVID-19HumansLeadershipPandemicsPneumonia, ViralSARS-CoV-2Security Measureshealth policyhealth systemshealth systems evaluationpublic health

Identifiers

PMID33033053
PMCPMC7545501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.